Artículo

Este artículo es de Acceso Abierto y puede ser descargado en su versión final desde nuestro repositorio
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

Background: In the present study, we demonstrate, in rigorous fashion, that human monocyte-derived immature dendritic cells (DCs) can efficiently cross-present tumor-associated antigens when co-cultured with a mixture of human melanoma cells rendered apoptotic/necrotic by γ irradiation (Apo-Nec cells). Methods: We evaluated the phagocytosis of Apo-Nec cells by FACS after PKH26 and PKH67 staining of DCs and Apo-Nec cells at different times of coculture. The kinetics of the process was also followed by electron microscopy. DCs maturation was also studied monitoring the expression of specific markers, migration towards specific chemokines and the ability to cross-present in vitro the native melanoma-associated Ags MelanA/MART-1 and gp100. Results: Apo-Nec cells were efficiently phagocytosed by immature DCs (iDC) (55 ± 10.5%) at 12 hs of coculture. By 12-24 hs we observed digested Apo-Nec cells inside DCs and large empty vacuoles as part of the cellular processing. Loading with Apo-Nec cells induced DCs maturation to levels achieved using LPS treatment, as measured by: i) the decrease in FITC - Dextran uptake (iDC: 81 ± 5%; DC/Apo-Nec 33 ± 12%); ii) the cell surface up-regulation of CD80, CD86, CD83, CCR7, CD40, HLA-I and HLA-II and iii) an increased in vitro migration towards MIP-3β. DC/Apo-Nec isolated from HLA-A*0201 donors were able to induce >600 pg/ml IFN-γ secretion of CTL clones specific for MelanA/MART-1 and gp100 Ags after 6 hs and up to 48 hs of coculture, demonstrating efficient cross-presentation of the native Ags. Intracellular IL-12 was detected in DC/Apo-Nec 24 hs post-coculture while IL-10 did not change. Conclusion: We conclude thatthe use of a mixture of four apoptotic/ necrotic melanoma cell lines is a suitable source of native melanoma Ags that provides maturation signals for DCs, increases migration to MIP-3β and allows Ag cross-presentation. This strategy could be exploited for vaccination of melanoma patients. © 2007 von Euw et al; licensee BioMed Central Ltd.

Registro:

Documento: Artículo
Título:Monocyte-derived dendritic cells loaded with a mixture of apoptotic/ necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8+ T lymphocytes
Autor:von Euw, E.M.; Barrio, M.M.; Furman, D.; Bianchini, M.; Levy, E.M.; Yee, C.; Li, Y.; Wainstok, R.; Mordoh, J.
Filiación:Fundación Instituto Leloir, Patricias Argentinas 435, 1405 Buenos Aires, Argentina
Centro de Investigaciones Oncológicas - FUCA, Cramer 1180, 1426 Buenos Aires, Argentina
Fred Hutchinson Cancer Research Centre, Clinical Research Division, 1100 Fairview Avenue N., Seattle, WA 98109-1024, United States
Departamento Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina
Palabras clave:B7 antigen; cancer vaccine; CD40 antigen; CD83 antigen; CD86 antigen; chemokine; chemokine receptor CCR7; dendritic cell vaccine; dextran; fluorescein isothiocyanate; gamma interferon; glycoprotein gp 100; HLA A antigen; HLA antigen; HLA antigen class 1; HLA antigen class 2; HLA antigen class 3; interleukin 10; interleukin 12; macrophage inflammatory protein 3beta; melan A; tumor antigen; unclassified drug; CCR7 protein, human; chemokine receptor CCR7; epitope; interleukin 10; interleukin 12; macrophage inflammatory protein 3beta; melan A; melanocyte protein Pmel 17; membrane protein; MLANA protein, human; SILV protein, human; tumor antigen; tumor protein; antigen expression; antigen specificity; apoptosis; article; CD8+ T lymphocyte; cell cloning; cell death; cell kinetics; cell maturation; cell migration; cell surface; cell vacuole; coculture; controlled study; cross presentation; cytokine release; cytotoxic T lymphocyte; dendritic cell; electron microscopy; fluorescence activated cell sorting; gamma irradiation; human; human cell; in vitro study; melanoma cell; monocyte; phagocytosis; upregulation; vaccination; apoptosis; cell differentiation; cell motion; cross presentation; cytology; drug effect; gamma radiation; immunology; melanoma; monocyte; necrosis; pathology; radiation exposure; time; tumor cell line; ultrastructure; Antigens, Neoplasm; Apoptosis; CD8-Positive T-Lymphocytes; Cell Differentiation; Cell Line, Tumor; Cell Movement; Chemokine CCL19; Coculture Techniques; Cross-Priming; Dendritic Cells; Epitopes; Gamma Rays; gp100 Melanoma Antigen; Humans; Interleukin-10; Interleukin-12; MART-1 Antigen; Melanoma; Membrane Glycoproteins; Monocytes; Necrosis; Neoplasm Proteins; Phagocytosis; Receptors, CCR7; Time Factors
Año:2007
Volumen:5
DOI: http://dx.doi.org/10.1186/1479-5876-5-19
Título revista:Journal of Translational Medicine
Título revista abreviado:J. Transl. Med.
ISSN:14795876
CAS:chemokine receptor CCR7, 231617-75-7; dextran, 87915-38-6, 9014-78-2; fluorescein isothiocyanate, 25168-13-2, 27072-45-3, 3326-32-7; gamma interferon, 82115-62-6; interleukin 12, 138415-13-1; macrophage inflammatory protein 3beta, 181030-14-8; Antigens, Neoplasm; CCR7 protein, human; Chemokine CCL19; Epitopes; Interleukin-10, 130068-27-8; Interleukin-12, 187348-17-0; MART-1 Antigen; MLANA protein, human; Membrane Glycoproteins; Neoplasm Proteins; Receptors, CCR7; SILV protein, human; gp100 Melanoma Antigen
PDF:https://bibliotecadigital.exactas.uba.ar/download/paper/paper_14795876_v5_n_p_vonEuw.pdf
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_14795876_v5_n_p_vonEuw

Referencias:

  • Banchereau, J., Steinman, R., Dendritic cells and the control of immunity (1998) Nature, 392, pp. 245-252. , 10.1038/32588 9521319
  • Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.J., Pulendran, B., Palucka, K., Immunobiology of dendritic cells (2000) Annu Rev Immunol, 18, pp. 767-811. , 10.1146/annurev.immunol.18.1.767 10837075
  • De Smedt, T., Pajal, B., Muraille, E., Lespagnard, L., Heinen, E., De Baetselier, P., Leo, O., Moser, M., Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo (1996) J Exp Med, 184, pp. 1413-1424. , 10.1084/jem.184.4.1413 8879213
  • Sparwasser, T., Koch, E.S., Vabulas, R.M., Heeg, K., Lipford, G.B., Ellwart, J.W., Wagner, H., Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells (1998) Eur J Immunol, 28, pp. 2045-2054. , 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8 9645386
  • Verdijk, R.M., Mutis, T., Esendam, B., Kamp, J., Melief, C.J., Brand, A., Goulmy, E., Polyriboinosinic polyribocytidylic acid (poly (I: C)) induces stable maturation of functionally active human dendritic cells (1999) J Immunol, 163, pp. 57-61. , 10384099
  • Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., Banchereau, J., Activation of human dendritic cells through CD40 cross-linking (1994) J Exp Med, 180, pp. 1263-1272. , 10.1084/jem.180.4.1263 7523569
  • Penna, G., Vulcano, M., Sozzani, S., Adorini, L., Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells (2002) Hum Immunol, 63, pp. 1164-1171. , 10.1016/S0198-8859(02)00755-3 12480260
  • Mellman, I., Steinman, R.M., Dendritic cells: Specialized and regulated antigen processing machines (2001) Cell, 106, pp. 255-258. , 10.1016/S0092-8674(01)00449-4 11509172
  • Nestle, F.O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., Schadendorf, D., Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells (1998) Nat Med, 4, pp. 328-332. , 10.1038/nm0398-328 9500607
  • Mayordomo, J.I., Zorina, T., Storkus, W.J., Zitvogel, L., Celluzzi, C., Falo, L.D., Melief, C.J., Deleo, A.B., Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity (1995) Nat Med, 1, pp. 1297-1302. , 10.1038/nm1295-1297
  • Celluzzi, C.M., Mayordomo, J.I., Storkus, W.J., Lotze, M.T., Falo Jr., L.D., Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity (1996) J Exp Med, 183, pp. 283-287. , 10.1084/jem.183.1.283 8551233
  • Goldszmid, R.S., Idoyaga, J., Bravo, A.I., Steinman, R., Mordoh, J., Wainstok, R., Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma (2003) J Immunol, 171, pp. 5940-5947. , 14634105
  • Scheffer, S.R., Nave, H., Korangy, F., Schlote, K., Pabst, R., Jaffee, E.M., Manns, M.P., Greten, T.F., Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo (2003) Int J Cancer, 103, pp. 205-211. , 10.1002/ijc.10777 12455034
  • Albert, M.L., Pearce, S.F., Francisco, L.M., Sauter, B., Roy, P., Silverstein, R.L., Bhardwaj, N., Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes (1998) J Exp Med, 188, pp. 1359-1368. , 10.1084/jem.188.7.1359 9763615
  • Chen, Z., Moyana, T., Saxena, A., Warrington, R., Jia, Z., Xiang, J., Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells (2001) Int J Cancer, 93, pp. 539-548. , 10.1002/ijc.1365 11477558
  • Shaif-Muthana, M., McIntyre, C., Sisley, K., Rennie, I., Murray, A., Dead or alive: Immunogenicity of human melanoma cells when presented by dendritic cells (2000) Cancer Res, 60, pp. 6441-6447. , 11103811
  • Pietra, G., Mortarini, R., Parmiani, G., Anichini, A., Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells (2001) Cancer Res, 61, pp. 8218-8226. , 11719453
  • Labarriere, N., Bretaudeau, L., Gervois, N., Bodinier, M., Bougras, G., Diez, E., Lang, F., Jotereau, F., Apoptotic body-loaded dendritic cells efficiently cross-prime cytotoxic T lymphocytes specific for NA17-A but not for Melan A/Mart-1 antigen (2002) Int J Cancer, 101, pp. 280-286. , 10.1002/ijc.10605 12209980
  • Demaria, S., Santori, F.R., Ng, B., Liebes, L., Formenti, S.C., Vukmanovic, S., Select forms of tumor cell apoptosis induce dendritic cell maturation (2005) J Leukoc Biol, 77, pp. 361-368. , 10.1189/jlb.0804478 15569694
  • Moehler, M.H., Zeidler, M., Wilsberg, V., Cornelis, J.J., Woelfel, T., Rommelaere, J., Galle, P.R., Heike, M., Parvovirus H-1-induced tumor cell death enhances human immune response in vitro via increased phagocytosis, maturation, and cross-presentation by dendritic cells (2005) Hum Gene Ther, 16, pp. 996-1005. , 10.1089/hum.2005.16.996 16076257
  • Russo, V., Tanzarella, S., Dalerba, P., Rigatti, D., Rovere, P., Villa, A., Bordignon, C., Traversari, C., Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response (2000) Proc Natl Acad Sci USA, 97, pp. 2185-2190. , 15775 10681453 10.1073/pnas.040540197
  • Motta, I., Andre, F., Lim, A., Tartaglia, J., Cox, W.I., Zitvogel, L., Angevin, E., Kourilsky, P., Cross-presentation by dendritic cells of tumor antigen expressed in apoptotic recombinant canarypox virus-infected dendritic cells (2001) J Immunol, 167, pp. 1795-1802. , 11466405
  • Gaipl, U.S., Beyer, T.D., Baumann, I., Voll, R.E., Stach, C.M., Heyder, P., Kalden, J.R., Herrmann, M., Exposure of anionic phospholipids serves as anti-inflammatory and immunosuppressive signal - Implications for antiphospholipid syndrome and systemic lupus erythematosus (2003) Immunobiology, 207, pp. 73-81. , 10.1078/0171-2985-00217 12638907
  • Palucka, A.K., Ueno, H., Connolly, J., Kerneis-Norvell, F., Blanck, J.P., Johnston, D.A., Fay, J., Banchereau, J., Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity (2006) J Immunother, 29, pp. 545-557. , 10.1097/01.cji.0000211309.90621.8b 16971810
  • Rohn, T.A., Schadendorf, D., Sun, Y., Nguyen, X.D., Roeder, D., Langen, H., Vogt, A.B., Kropshofer, H., Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells (2005) Eur J Immunol, 35, pp. 2826-2839. , 10.1002/eji.200526299 16163671
  • Yee, C., Thompson, J.A., Byrd, D., Riddell, S.R., Roche, P., Celis, E., Greenberg, P.D., Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells (2002) Proc Natl Acad Sci USA, 99, pp. 16168-16173. , 138583 12427970 10.1073/pnas.242600099
  • Hamburger, A.W., The human tumor clonogenic assay as a model system in cell biology (1987) Inter J Cell Cloning, 5, pp. 89-107
  • Berard, F., Blanco, P., Davoust, J., Neidhart-Berard, E.M., Nouri-Shirazi, M., Taquet, N., Rimoldi, D., Palucka, A.K., Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells (2000) J Exp Med, 192, pp. 1535-1544. , 10.1084/jem.192.11.1535 11104796
  • Ferlazzo, G., Semino, C., Spaggiari, G.M., Meta, M., Mingari, M.C., Melioli, G., Dendritic cells efficiently cross-prime HLA class I-restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates (2000) Int Immunol, 12, pp. 1741-1747. , 10.1093/intimm/12.12.1741 11099314
  • Albert, M.L., Sauter, B., Bhardwaj, N., Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs (1998) Nature, 392, pp. 86-89. , 10.1038/32183 9510252
  • Gallucci, S., Lolkema, M., Matzinger, P., Natural adjuvants: Endogenous activators of dendritic cells (1999) Nature Medicine, 5, pp. 1249-1255. , 10.1038/15200 10545990
  • Sauter, B., Albert, M.L., Francisco, L., Larsson, M., Somersan, S., Bardwaj, N., Consequences of cell death: Exposure to necrotic tumor cells, but not Primary Tissue cells or apoptotic cells, induces the maturation of Immunostimulatory Dendritic cells (2000) J Exp Med, 191, pp. 423-433. , 10.1084/jem.191.3.423 10662788
  • Jarnjak-Jankovic, S., Pettersen, R.D., Saeboe-Larssen, S., Wesenberg, F., Gaudernack, G., Evaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemia (2005) BMC Cancer, pp. 5-20. , 547906 15651986
  • Di Nicola, M., Napoli, S., Anichini, A., Mortarini, R., Romagnoli, L., Magni, M., Matteucci, P., Gianni, A.M., Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection (2003) Haematologica, 88, pp. 1396-1404. , 14687994
  • Linette, G.P., Zhang, D., Hodi, F.S., Jonasch, E.P., Longerich, S., Stowell, C.P., Webb, I.J., Haluska, F.G., Immunization using autologous dendritic cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunity (2005) Clin Cancer Res, 11, pp. 7692-7699. , 10.1158/1078-0432.CCR-05-1198 16278389
  • Andersen, M.H., Keikavoussi, P., Broker, E.B., Schuler-Thurner, B., Jonassen, M., Sondergaard, I., Straten, P.T., Kampgen, E., Induction of CTL responses in melanoma patients by dfendritic cell vaccination: Cessation of CTL responses is associated with disease progression (2001) Int J Cancer, 94, p. 820. , 10.1002/ijc.1536 11745484
  • Blachere, N.E., Darnell, R.B., Albert, M.L., Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation (2005) PLoS Biol, 3, pp. e185. , 1084338 15839733 10.1371/journal.pbio.0030185
  • Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Thery, C., Masurier, C., Flament, C., Zitvogel, L., Tumor-derived exososmes are a source of shared tumor rejection antigens for CTL cross-priming (2001) Nature Medicine, 7, pp. 297-303. , 10.1038/85438 11231627
  • Hirao, M., Onai, N., Hiroishi, K., Watkins, S.C., Matsushima, K., Robbins, P.D., Lotze, M.T., Tahara, H., CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: Critical role in migration from the tumor site to draining lymph nodes (2000) Cancer Res, 60, pp. 2209-2217. , 10786686
  • Xu, S., Koldovsky, U., Xu, M., Wang, D., Fitzpatrick, E., Son, G., Koski, G., Czerniecki, High-avidity antitumor T-cell generation by toll receptor 8-primed, myeloid- derived dendritic cells is mediated by IL- the induction of IL-12 by TLR8 12 production (2006) BJ Surgery, 140, pp. 170-178. , 10.1016/j.surg.2006.03.006
  • Caetano, R., Dendritic cells in a mature age (2006) Nature Rev Immunol, 6, pp. 476-483. , 10.1038/nri1845

Citas:

---------- APA ----------
von Euw, E.M., Barrio, M.M., Furman, D., Bianchini, M., Levy, E.M., Yee, C., Li, Y.,..., Mordoh, J. (2007) . Monocyte-derived dendritic cells loaded with a mixture of apoptotic/ necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8+ T lymphocytes. Journal of Translational Medicine, 5.
http://dx.doi.org/10.1186/1479-5876-5-19
---------- CHICAGO ----------
von Euw, E.M., Barrio, M.M., Furman, D., Bianchini, M., Levy, E.M., Yee, C., et al. "Monocyte-derived dendritic cells loaded with a mixture of apoptotic/ necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8+ T lymphocytes" . Journal of Translational Medicine 5 (2007).
http://dx.doi.org/10.1186/1479-5876-5-19
---------- MLA ----------
von Euw, E.M., Barrio, M.M., Furman, D., Bianchini, M., Levy, E.M., Yee, C., et al. "Monocyte-derived dendritic cells loaded with a mixture of apoptotic/ necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8+ T lymphocytes" . Journal of Translational Medicine, vol. 5, 2007.
http://dx.doi.org/10.1186/1479-5876-5-19
---------- VANCOUVER ----------
von Euw, E.M., Barrio, M.M., Furman, D., Bianchini, M., Levy, E.M., Yee, C., et al. Monocyte-derived dendritic cells loaded with a mixture of apoptotic/ necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8+ T lymphocytes. J. Transl. Med. 2007;5.
http://dx.doi.org/10.1186/1479-5876-5-19